FDA Clearance Tracker · K253609
TRAUMAGEL® 2.0 Hemostatic Gel
Last checked: Nov 19, 2026Latest source record: Dec 12, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 12, 2025
Substantially Equivalent
Time to decision
24 days
Received Nov 18, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Unclassified
The decision
- FDA number
- K253609
- Device name
- TRAUMAGEL® 2.0 Hemostatic Gel
- Applicant
- Cresilon, Inc.
- Applicant location
- Brooklyn, NY
- Received
- Nov 18, 2025
- Decided
- Dec 12, 2025
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Unclassified
- Specialty
- General & Plastic SurgeryWound Care
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QSY. The earliest in FDA's data is K893123, decided Feb 13, 1990.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K253609
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Cresilon, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TRAUMAGEL®510(k)
K240713 · Decided Aug 14, 2024 · 152 days after receipt
Device type: Hemostatic Wound Dressing Without Thrombin Or Other Biologics (QSY) · General & Plastic Surgery
K213652 · Decided Jun 28, 2023 · 586 days after receipt
Device type: Hemostatic Wound Dressing Without Thrombin Or Other Biologics (QSY) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.